Detection of Human Alu Sequences in Rodent Genomic DNA Background

Detecting Human Alu Sequences

Human Alu sequences are a class of repetitive DNA elements found in the human genome that can copy and insert into different locations. PCR analysis allows developers to quantify cells or DNA in preclinical models and track where these therapies travel and persist.

Pharmaron has qualified a qPCR method for detecting human Alu elements in rodent genomic DNA backgrounds. The case study below summarizes this method qualification.

Biodistribution

Regulatory agencies require biodistribution data before cell-based therapies can advance to clinical trials. The FDA recommends that developers characterize the distribution, persistence, and clearance of cell therapy products in relevant animal models as part of their preclinical testing. A reliable detection method must distinguish human DNA from the animal host background with high specificity and sensitivity to detect small quantities of human material across multiple tissue types.

Case Study: Qualified qPCR Method for Human Alu Detection

Pharmaron qualified a non-GLP qPCR method using standard curves containing rodent genomic DNA spiked with varying amounts of hgDNA. The qualification assessed specificity, sensitivity, assay range, standard curve performance and precision and accuracy across tissue and blood matrices from two immunodeficient rodent strains. The full case study includes detailed assay parameters, acceptance criteria, and amplification data.

Download the Case Study

Review the method qualification, consisting of assay range, quantification limits, precision, and accuracy data across all tested matrices.

References:

• FDA: Preclinical Assessment of Investigational Cellular and Gene Therapy Products (Guidance for Industry)
• Becker et al. (2017). Highly sensitive and specific Alu-based quantification of human cells among rodent cells
• Multi-site evaluation (2024): Using qPCR and ddPCRto study biodistribution of cell therapy products.